ARCORAL Trademark

Trademark Overview

On Wednesday, August 27, 2008, a trademark application was filed for ARCORAL with the United States Patent and Trademark Office. The USPTO has given the ARCORAL trademark a serial number of 77556504. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 13, 2019. This trademark is owned by Arco Interpharma AS. The ARCORAL trademark is filed in the Pharmaceutical Products category with the following description:

preparations for the prevention and treatment of infections in hard and soft tissue within the oral cavity; preparations for countering the effects of chemotherapy and/or radiotherapy
arcoral

General Information

Serial Number77556504
Word MarkARCORAL
Filing DateWednesday, August 27, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 13, 2019
Registration Number3618791
Registration DateTuesday, May 12, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 24, 2009

Trademark Statements

Goods and Servicespreparations for the prevention and treatment of infections in hard and soft tissue within the oral cavity; preparations for countering the effects of chemotherapy and/or radiotherapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 13, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameArco Interpharma AS
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHokksund 3301
NO
Party NameArco Interpharma AS
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHokksund 3301
NO
Party NameArco Interpharma AS
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHokksund 3301
NO

Trademark Events

Event DateEvent Description
Friday, December 13, 2019CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, May 12, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, February 26, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 15, 2016NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, January 15, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, November 6, 2015POST REGISTRATION ACTION MAILED - SEC. 8
Wednesday, October 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 28, 2015TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, April 28, 2015POST REGISTRATION ACTION MAILED - SEC. 8
Tuesday, April 28, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 24, 2015TEAS SECTION 8 RECEIVED
Wednesday, July 18, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 18, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 12, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, February 24, 2009PUBLISHED FOR OPPOSITION
Wednesday, February 4, 2009NOTICE OF PUBLICATION
Friday, January 16, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 14, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 14, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 14, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 14, 2009ASSIGNED TO LIE
Wednesday, January 7, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 5, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 5, 2008NON-FINAL ACTION E-MAILED
Friday, December 5, 2008NON-FINAL ACTION WRITTEN
Friday, December 5, 2008ASSIGNED TO EXAMINER
Wednesday, September 3, 2008NOTICE OF PSEUDO MARK MAILED
Tuesday, September 2, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

arcoral preparations cavity countering effects radiotherapy chemotherapy oral tissue treatment prevention